(Updated - August 10, 2026 9:22 AM EDT)

Stifel analyst Paul Matteis downgraded Sionna Therapeutics (NASDAQ: SION) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE